Search
13th Global DDF Summit - Drug Delivery Formulation
Hovione receives the 2023 CDMO Leadership Award in all six categories and is Champion in Compatibility and Expertise
Hovione won the 2023 CDMO Leadership Award across all six categories across all three groups of respondents
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
Pharma manufacturer Hovione announces 48 new jobs for Cork
Silicon Republic, October 2, 2020
Hovione expands nasal drug delivery capabilities with the development of nasal powder delivery device technology in collaboration with IDC
Hovione, the specialist integrated CDMO, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.
Continuous Tableting for Drug Product
Hovione´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.
Sunriser® DPI
High Performance, High-Dose Capsule DPI.